Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection

NCT07729839 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants

Interventions

DRUG: ADB116 for Injection
DRUG: Placebo for ADB116 for Injection

Sponsor

Jiangsu Aidea Pharmaceutical Group Co., Ltd.